Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03799198 · ClinicalTrials.gov registry record · Phase 4

Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

A Phase 4 study, sponsored by Novo Nordisk A/S.

Completed
Registry status
Phase 4
Development phase
200
Enrollment target

NCT03799198 is a Phase 4 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03799198, a Phase 4 study, has completed, sponsored by Novo Nordisk A/S.

COMPLETED
Registry status
Phase 4
Development phase
200 participants
Enrollment target

Study Summary

Researchers are doing this study to compare the effects of drugs approved for long-term weight loss combined with an employer-based weight management program with the effects of the weight management program without drugs for weight loss. If participants agree to be in this study, they will join the Cleveland Clinic Integrated Medical Weight Management Program (WMP). Participants will be assigned by chance (like flipping a coin) to one of two treatment groups: A) Group 1: Cleveland Clinic Integrated Medical WMP + medication for long-term weight loss. B) Group 2: Cleveland Clinic Integrated Medical WMP without medication for weight loss. Participants have an equal chance of being in either of the treatment groups. The total study duration for the individual participants will be approximately one year.

Interventions

  • OTHER Weight Management Program (WMP)
  • DRUG Medication for chronic weight management (Rx)

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-01-07
Est. Completion 2020-05-22
Phase Phase 4

Sponsor

Novo Nordisk A/S

431 total trials

What the Registry Record Tells You About NCT03799198

The ClinicalTrials.gov registry entry for NCT03799198 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Weight Management Program (WMP) is the first listed.

NCT03799198 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03799198 about?

NCT03799198 is a clinical study titled "Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity". Researchers are doing this study to compare the effects of drugs approved for long-term weight loss combined with an employer-based weight management program with the effects of the weight management program without drugs for weight loss. If participants agree to be in this study, they will join the...

What is the current status of trial NCT03799198?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2019-01-07. Estimated completion is 2020-05-22.

What interventions are being tested in trial NCT03799198?

The interventions under investigation include: Weight Management Program (WMP) (OTHER), Medication for chronic weight management (Rx) (DRUG).

Who is sponsoring clinical trial NCT03799198?

This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.